- Home
- FRT vs QGEN Comparison
FRT vs QGEN Comparison
Compare FRT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRT | QGEN |
|---|---|---|
| Founded | 1962 | 1986 |
| Country | United States | Netherlands |
| Employees | 320 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 10.2B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | FRT | QGEN |
|---|---|---|
| Price | $112.18 | $41.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $112.08 | $50.26 |
| AVG Volume (30 Days) | 854.5K | ★ 1.3M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | 4.02% | ★ 5.84% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.10 | $8.18 |
| Revenue Next Year | $4.64 | $5.71 |
| P/E Ratio | ★ $22.54 | $24.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $89.99 | $38.80 |
| 52 Week High | $112.52 | $57.82 |
Technical Indicators
Market Signals| Indicator | FRT | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 72.22 | 44.85 |
| Support Level | $103.41 | $38.80 |
| Resistance Level | N/A | $48.53 |
| Average True Range (ATR) | 1.66 | 0.79 |
| MACD | 0.62 | 0.34 |
| Stochastic Oscillator | 90.43 | 53.32 |
Price Performance
Historical ComparisonAbout FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 104 properties, which includes 28.8 million square feet of retail space and 2,700 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).